Weiguo Ye, Chief Operating Officer at GYRE THERAPEUTICS, INC. (GYRE), sold 34,976 shares at $6.13 ($219K) on 2026-06-04, disclosed to the SEC on 2026-06-08.
Open-market sale of $219k GYRE by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.13 | 19,575 | $120K | 54.9% |
| 2 | $6.40 | 15,401 | $99K | 45.1% |
| Total | $6.25 avg | 34,976 | $219K | 100% |
| Filing → |
| GYRE | SELL | 2026-06-11 | $129K | — | Filing → |
| GYRE | SELL | 2026-05-27 | $46K | — | Filing → |
| GYRE | SELL | 2026-05-22 | $137K | — | Filing → |